# ABCA2

## Overview
The ABCA2 gene encodes the ATP-binding cassette subfamily A member 2 protein, which is a crucial component of the ATP-binding cassette (ABC) transporter family. This family of proteins is characterized by their role in the translocation of various molecules across cellular membranes, utilizing energy derived from ATP hydrolysis. ABCA2 is predominantly expressed in the brain, particularly within oligodendrocytes, and is involved in critical processes such as cholesterol homeostasis and lipid transport (Mack2006The; Albrecht2006The). The protein's structure includes two transmembrane domains and two nucleotide-binding domains, which facilitate its function in intracellular cholesterol trafficking and myelin sheath formation in the central nervous system (Davis2018ATPbinding; Mack2008ABCA2). ABCA2's expression is sensitive to sterol levels, underscoring its role in lipid metabolism and cellular responses to cholesterol fluctuations (Kaminski2006ABC).

## Structure
The ABCA2 protein is a member of the ATP-binding cassette (ABC) transporter family, characterized by a structure that includes two transmembrane domains (TMDs) and two nucleotide-binding domains (NBDs) (Davis2018ATPbinding; Mack2008ABCA2). The primary structure of ABCA2 consists of 2,436 amino acids, with a molecular mass of approximately 270 kDa (Mack2008ABCA2; Kaminski2006ABC). The protein is encoded by the ABCA2 gene located on chromosome 9q34, spanning 48 exons (Mack2008ABCA2).

ABCA2 contains conserved sequences such as LLLWKN and VFVNFA, which are critical for its function (Mack2008ABCA2). The protein also features a unique lipocalin signature sequence, forming a small pocket for binding hydrophobic compounds (Mack2008ABCA2). The secondary structure includes hydrophobic segments distributed across the TMDs, with seven segments in each domain (ZHAO2000Cloning).

ABCA2 is a glycosylated protein, with potential phosphorylation sites, including cAMP-dependent, protein kinase C-dependent, and tyrosine kinase-dependent sites located in the NBDs (ZHAO2000Cloning). Two isoforms, 1A and 1B, are generated by alternative splicing, differing in the number of amino acids encoded by their first exons (Davis2018ATPbinding; Mack2008ABCA2). These isoforms share similar expression profiles and co-localize with lysosome-associated membrane proteins (Mack2006The).

## Function
The ABCA2 gene encodes a protein that is part of the ATP-binding cassette (ABC) transporter family, which is involved in the translocation of various molecules across cellular membranes using energy from ATP hydrolysis. ABCA2 is predominantly expressed in the brain, particularly in oligodendrocytes, and is involved in cholesterol homeostasis and lipid transport (Mack2006The; Albrecht2006The). It plays a crucial role in the intracellular trafficking of low-density lipoprotein (LDL)-derived free cholesterol, influencing its movement from lysosomes to the plasma membrane and endoplasmic reticulum (Davis2004Human). This process is essential for maintaining cellular cholesterol balance and is linked to the regulation of genes involved in cholesterol uptake and synthesis, such as the low-density lipoprotein receptor (LDLR) and 3-hydroxy-3-methylglutaryl CoA synthase (HMGCoA S) (Davis2004Human).

ABCA2 is also implicated in the formation of myelin sheaths in the central nervous system, highlighting its importance in neural development (Mack2006The). The protein is localized in late endosomes/lysosomes and the trans-Golgi network, suggesting its involvement in vesicular transport processes (Davis2004Human). Its expression is sensitive to sterol levels, indicating a role in lipid metabolism and cellular response to cholesterol fluctuations (Kaminski2006ABC).

## Clinical Significance
Mutations and alterations in the ABCA2 gene are linked to several diseases and conditions, particularly in the context of neurological disorders and cancer. In Alzheimer's disease (AD), ABCA2 is associated with both early-onset and sporadic late-onset forms. A specific synonymous single nucleotide polymorphism (SNP), rs908832, in exon 14 of ABCA2, has been linked to AD, affecting amyloid precursor protein (APP) processing and increasing amyloid-beta (Aβ) production, a hallmark of AD pathology (Davis2018ATPbinding; Mack2008ABCA2). ABCA2's role in cholesterol metabolism is also significant in AD, as elevated cholesterol levels in cerebrospinal fluid are a risk factor (Mack2007“Skittish”).

In cancer, ABCA2 is implicated in drug resistance, particularly in acute myeloid leukemia (AML) and T-cell acute lymphoblastic leukemia (T-ALL), where its expression is linked to resistance against various anticancer drugs (Davis2018ATPbinding; Mack2008ABCA2). ABCA2 is also highly expressed in certain brain tumors, such as vestibular schwannomas and oligodendrogliomas, and is considered a potential biomarker for these cancers (Mack2008ABCA2).

ABCA2 mutations are also associated with cerebellar ataxia and dysarthria, as demonstrated by a study identifying a variant, c.4993delG:p., linked to these symptoms in a family (Aslam2019Ataxia).


## References


[1. (ZHAO2000Cloning) Li-Xia ZHAO, Cheng-Ji ZHOU, Arowu TANAKA, Masanori NAKATA, Takahiro HIRABAYASHI, Teruo AMACHI, Seiji SHIODA, Kazumitsu UEDA, and Nobuya INAGAKI. Cloning, characterization and tissue distribution of the rat atp-binding cassette (abc) transporter abc2/abca2. Biochemical Journal, 350(3):865–872, September 2000. URL: http://dx.doi.org/10.1042/bj3500865, doi:10.1042/bj3500865. This article has 21 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj3500865)

[2. (Aslam2019Ataxia) Faiza Aslam and Sadaf Naz. Ataxia and dysarthria due to an abca2 variant: extension of the phenotypic spectrum. Parkinsonism &amp; Related Disorders, 64:328–331, July 2019. URL: http://dx.doi.org/10.1016/j.parkreldis.2019.04.017, doi:10.1016/j.parkreldis.2019.04.017. This article has 3 citations.](https://doi.org/10.1016/j.parkreldis.2019.04.017)

[3. (Davis2018ATPbinding) Warren Davis and Kenneth D. Tew. Atp-binding cassette transporter-2 (abca2) as a therapeutic target. Biochemical Pharmacology, 151:188–200, May 2018. URL: http://dx.doi.org/10.1016/j.bcp.2017.11.018, doi:10.1016/j.bcp.2017.11.018. This article has 26 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.bcp.2017.11.018)

[4. (Kaminski2006ABC) Wolfgang E. Kaminski, Armin Piehler, and Jürgen J. Wenzel. Abc a-subfamily transporters: structure, function and disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1762(5):510–524, May 2006. URL: http://dx.doi.org/10.1016/j.bbadis.2006.01.011, doi:10.1016/j.bbadis.2006.01.011. This article has 147 citations.](https://doi.org/10.1016/j.bbadis.2006.01.011)

[5. (Albrecht2006The) Christiane Albrecht and Enrique Viturro. The abca subfamily—gene and protein structures, functions and associated hereditary diseases. Pflügers Archiv - European Journal of Physiology, 453(5):581–589, April 2006. URL: http://dx.doi.org/10.1007/s00424-006-0047-8, doi:10.1007/s00424-006-0047-8. This article has 88 citations.](https://doi.org/10.1007/s00424-006-0047-8)

[6. (Mack2007“Skittish”) Jody T. Mack, Vladimir Beljanski, Athena M. Soulika, Danyelle M. Townsend, Carol B. Brown, Warren Davis, and Kenneth D. Tew. “skittish” abca2 knockout mice display tremor, hyperactivity, and abnormal myelin ultrastructure in the central nervous system. Molecular and Cellular Biology, 27(1):44–53, January 2007. URL: http://dx.doi.org/10.1128/mcb.01824-06, doi:10.1128/mcb.01824-06. This article has 32 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.01824-06)

[7. (Davis2004Human) Warren Davis, Jonathan T Boyd, Kristina E Ile, and Kenneth D Tew. Human atp-binding cassette transporter-2 (abca2) positively regulates low-density lipoprotein receptor expression and negatively regulates cholesterol esterification in chinese hamster ovary cells. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1683(1–3):89–100, July 2004. URL: http://dx.doi.org/10.1016/j.bbalip.2004.04.009, doi:10.1016/j.bbalip.2004.04.009. This article has 29 citations.](https://doi.org/10.1016/j.bbalip.2004.04.009)

[8. (Mack2006The) J.T. Mack, V. Beljanski, K.D. Tew, and D.M. Townsend. The atp-binding cassette transporter abca2 as a mediator of intracellular trafficking. Biomedicine &amp; Pharmacotherapy, 60(9):587–592, November 2006. URL: http://dx.doi.org/10.1016/j.biopha.2006.07.090, doi:10.1016/j.biopha.2006.07.090. This article has 27 citations.](https://doi.org/10.1016/j.biopha.2006.07.090)

[9. (Mack2008ABCA2) Jody T Mack, Carol B Brown, and Kenneth D Tew. Abca2 as a therapeutic target in cancer and nervous system disorders. Expert Opinion on Therapeutic Targets, 12(4):491–504, March 2008. URL: http://dx.doi.org/10.1517/14728222.12.4.491, doi:10.1517/14728222.12.4.491. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1517/14728222.12.4.491)